TOTALIP Side Effects

6779446-2 | Enterocolitis, Rhabdomyolysis
on Jun 09, 2010 Female patient from ITALY , 82 years of age, was diagnosed with hypercholesterolaemia, arthralgia, hyperuricaemia and was treated with Totalip (View Usage). Patient experienced the following unwanted or unexpected effects: enterocolitis, rhabdomyolysis. Totalip dosage: 20 Mg, X/day. During the same period patient was treated with COLCHICINE (1 Mg, X/day) (View Colchicine Review and Colchicine Label ), ALLOPURINOL (150 Mg, Unk) (View Allopurinol Review and Allopurinol Label ), ARANESP (20 Ug) (View Aranesp Review and Aranesp Label ), COTAREG ^NOVARTIS^ (View Cotareg ^novartis^ Review and Cotareg ^novartis^ Label ), ACETYLSALICYLATE LYSINE (View Acetylsalicylate Lysine Review and Acetylsalicylate Lysine Label ), CATAPRESAN (View Catapresan Review and Catapresan Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), CALCIFEDIOL (View Calcifediol Review and Calcifediol Label ). Patient was hospitalized.

6488797-0 | Haematoma, Thrombocytopenia
Patient was taking Totalip (View Usage). Patient had the following side effects: haematoma, thrombocytopenia on Dec 03, 2009 from ITALY Additional patient health information: Female patient , 76 years of age, was diagnosed with myocardial ischaemia and. Totalip dosage: 20 Mg, X/day. During the same period patient was treated with BISOPROLOL (Unk) (View Bisoprolol Review and Bisoprolol Label ), NORVASC (Unk) (View Norvasc Review and Norvasc Label ), TORASEMIDE SODIUM (Unk) (View Torasemide Sodium Review and Torasemide Sodium Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ), PROTAPHANE HM (10 International Units (lower Than 100)) (View Protaphane Hm Review and Protaphane Hm Label ), OMEGA 3 TRIGLYCERIDES (Unk) (View Omega-3 Triglycerides Review and Omega-3 Triglycerides Label ), COTAREG ^NOVARTIS^ (Unk) (View Cotareg ^novartis^ Review and Cotareg ^novartis^ Label ). Patient was hospitalized.

6464502-9 | Alveolitis
Adverse event was reported on Nov 27, 2009 by a Male patient taking Totalip (View Usage) (Dosage: 40 Mg, 1x/day) was diagnosed with dyslipidaemia and. Location: ITALY , 66 years of age, After Totalip was administered, patient had the following side effects: alveolitis. During the same period patient was treated with 5 ASA (100 Mg, Unk) (View 5-asa Review and 5-asa Label ), LEVOTHYROXINE (75 Ug, Unk) (View Levothyroxine Review and Levothyroxine Label ), CARDICOR (Unk) (View Cardicor Review and Cardicor Label ), VASERETIC (20 Mg/12.5 Mg, Unk) (View Vaseretic Review and Vaseretic Label ), ADALAT (30 Mg, Unk) (View Adalat Review and Adalat Label ). Patient was hospitalized.

6457303-9 | Asthenia, Dyspnoea, Hypothyroidism, Rhabdomyolysis
on Oct 08, 2009 Female patient from ITALY , 72 years of age, was diagnosed with dyslipidaemia and was treated with Totalip (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dyspnoea, hypothyroidism, rhabdomyolysis. Totalip dosage: 5 Mg, Unk. During the same period patient was treated with VERAPAMIL HYDROCHLORIDE (160 Mg, Unk) (View Verapamil Hydrochloride Review and Verapamil Hydrochloride Label ), ALPRAZOLAM (0.5 Mg, Unk) (View Alprazolam Review and Alprazolam Label ), QUINAZIL (View Quinazil Review and Quinazil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DISOPYRAMIDE PHOSPHATE (View Disopyramide Phosphate Review and Disopyramide Phosphate Label ), ALDACTAZIDE (View Aldactazide Review and Aldactazide Label ). Patient was hospitalized.


6447115-4 | Agitation, Blood Creatine Phosphokinase Increased, Confusional State, Myoglobinaemia, Vomiting
on Nov 16, 2009 Female patient from ITALY , 70 years of age, was diagnosed with hypercholesterolaemia and was treated with Totalip (View Usage). Patient had the following side effects: agitation, blood creatine phosphokinase increased, confusional state, myoglobinaemia, vomiting. Totalip dosage: 40 Mg, 1x/day. During the same period patient was treated with PERINDOPRIL ERBUMINE/INDAPAMIDE HEMIHYDRATE (View Perindopril Erbumine/indapamide Hemihydrate Review and Perindopril Erbumine/indapamide Hemihydrate Label ). Patient was hospitalized.

6425465-5 | Liver Injury
Patient was taking Totalip (View Usage). After Totalip was administered, patient had the following side effects: liver injury on Oct 30, 2009 from ITALY Additional patient health information: Female patient , 77 years of age, . Totalip dosage: Unk. During the same period patient was treated with LOPRESSOR (Unk) (View Lopressor Review and Lopressor Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ), ESKIM (Unk) (View Eskim Review and Eskim Label ), PLAUNAC (Unk) (View Plaunac Review and Plaunac Label ).

6408997-5 | Alveolitis
Adverse event was reported on Oct 13, 2009 by a Female patient taking Totalip (View Usage) (Dosage: 40 Mg, 1x/day) was diagnosed with dyslipidaemia and. Location: ITALY , 66 years of age, Patient experienced the following unwanted or unexpected effects: alveolitis. During the same period patient was treated with 5 ASA (100 Mg, Unk) (View 5-asa Review and 5-asa Label ), LEVOTHYROXINE (75 Ug, Unk) (View Levothyroxine Review and Levothyroxine Label ), CARDICOR (Unk) (View Cardicor Review and Cardicor Label ), VASERETIC (20 Mg/12.5 Mg, Unk) (View Vaseretic Review and Vaseretic Label ), ADALAT (30 Mg, Unk) (View Adalat Review and Adalat Label ). Patient was hospitalized.

6398355-4 | Agitation, Confusional State, Vomiting
on Oct 02, 2009 Female patient from ITALY , 70 years of age, was diagnosed with hypercholesterolaemia and was treated with Totalip (View Usage). Patient had the following side effects: agitation, confusional state, vomiting. Totalip dosage: 40 Mg, 1x/day. During the same period patient was treated with PERINDOPRIL ERBUMINE/INDAPAMIDE HEMIHYDRATE (View Perindopril Erbumine/indapamide Hemihydrate Review and Perindopril Erbumine/indapamide Hemihydrate Label ). Patient was hospitalized.

6375217-X | Liver Injury
on Sep 16, 2009 Female patient from ITALY , 77 years of age, was treated with Totalip (View Usage). After Totalip was administered, patient had the following side effects: liver injury. Totalip dosage: Unk. During the same period patient was treated with LOPRESSOR (Unk) (View Lopressor Review and Lopressor Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ), ESKIM (Unk) (View Eskim Review and Eskim Label ), PLAUNAC (Unk) (View Plaunac Review and Plaunac Label ).